Compare ENSC & GVH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | ENSC | GVH |
|---|---|---|
| Founded | 2003 | 2016 |
| Country | United States | Australia |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | |
| Sector | Health Care | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.7M | 2.7M |
| IPO Year | N/A | 2023 |
| Metric | ENSC | GVH |
|---|---|---|
| Price | $0.53 | $1.22 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 1 |
| Target Price | N/A | ★ $80.00 |
| AVG Volume (30 Days) | ★ 11.2M | 2.9M |
| Earning Date | 01-01-0001 | 01-01-0001 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | $102,768.97 |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | $0.74 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $0.31 | $0.03 |
| 52 Week High | $4.90 | $10.74 |
| Indicator | ENSC | GVH |
|---|---|---|
| Relative Strength Index (RSI) | 47.32 | 45.95 |
| Support Level | $0.31 | $0.88 |
| Resistance Level | $0.73 | $1.79 |
| Average True Range (ATR) | 0.08 | 0.13 |
| MACD | 0.04 | 0.04 |
| Stochastic Oscillator | 48.51 | 51.43 |
Ensysce Biosciences Inc is a clinical-stage biotech company using its proprietary technology platforms to develop safer prescription drugs. The company is developing a new class of powerful, tamper-proof opioids that prevent both drug abuse and overdoses. Its products are anticipated to provide safer options to treat severe pain and assist in preventing deaths caused by opioid abuse, reducing human and economic costs. The company's current development pipeline includes two new drug platforms: an abuse-resistant opioid prodrug technology, theTrypsin Activated Abuse Protection, or the TAAP platform, and an over-dose protection opioid prodrug technology, the Multi-Pill Abuse Resistant, or the MPAR platform. The Company currently operates in one business segment, which is pharmaceuticals.
Globavend Holdings Ltd is an e-commerce logistics provider, it provides integrated cross-border logistics services from Hong Kong to Australia and New Zealand, where it provides customers with a one-stop solution from parcel consolidation to air freight forwarding, customs clearance, on-carriage parcel transportation and delivery. It operates in logistics and freight forwarding industry, which involves the provision of services such as freight transport, freight forwarding, warehouse management, and distribution.